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Human parvovirus B19 is a well-known cause of severe conditions in patients with sickle cell
disease,  but the molecular mechanisms of the infection are insufﬁciently understood. The
different clinical outcome of the acute parvovirus B19 infection in two pediatric patients with
sickle  cell disease has been examined. One of them developed life-threatening condition
requiring  emergency transfusions, while the other had asymptomatic infection, diagnosed
occasionally.  Both cases had high viral load and identical subgenotype, indicating that theuman parvovirus B19
iral  load
plastic crisis
ubgenotypes
viral  molecular characteristics play a minimal role in the infection outcome.
© 2013 Elsevier Editora Ltda.      Este é um artigo Open Access sob a licença de CC BY-NC-NDntroduction
uman parvovirus B19 (B19V) causes a broad spectrum of
linical  conditions, ranging from mild to life-threatening.1
he acute infection in healthy children leads to erythema
nfectiosum, which is a mild febrile exanthema, but pediatric
atients with hemoglobinopathies often develop transient
plastic  crisis (TAC).2 The progression of TAC can lead to severe
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Este é um artigo Open Access sob a licença and even fatal anemia resulting in congestive heart failure,
cerebrovascular collapse,3 and acute splenic sequestration.4
Myocarditis, arthritis, nephrotic syndrome5 and fatal bone
marrow  embolism6 due to B19V have also been reported in
patients  with sickle cell disease (SCD).
On the contrary, some SCD patients can develop subclinicalbeirão Preto, São Paulo, SP, Brazil. Tel.: +55 1621019300x9680;
B19V  infection. The reason why they do not represent clinical
symptomatology is obscure, but different factors like aplasia
duration  and severity, fetal hemoglobin concentrations and
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Table 1 – Changes of the hematological parameters of the examined children during the acute parvovirus B19 infection.
Case report number Blood parameters Baseline values Sample no. 1 Sample no. 2
Case report no. 1 Hemoglobin 11.0 g/dL 10.5 g/dL 10.6 g/dL
Hematocrit 35% 33% 33%
Leukocytes 12,300 6700 6500
Neutrophils 5700 2400 2000
Lymphocytes 4500 2500 2600
Platelets 201,000 122,000 201,000
Reticulocytes 1% 0.3% 1%
Case report no. 2 Hemoglobin 7.8 g/dL 4.4 g/dL 8.1 g/dL
Hematocrit 26% 14% 28%
Leukocytes 11,900 18,200 9300
Neutrophils 6900 2900 4000
Lymphocytes 3900 14,400 4500
Platelets 
Reticulocytes 
genetic modiﬁers have been implicated.7 Moreover, the ele-
vated  high substitution rates of B19V have also been regarded
as  infection modiﬁers.8
This case report comparison examines the contrasting out-
come  of B19V infection in two children with SCD during
a  nosocomial B19V outbreak in the Hemotherapy Center of
Ribeirão  Preto, Brazil. Despite the identical B19V subgenotypes
and  high viral load, the patients presented different clinical
and  laboratory pictures. B19V molecular and genotypic fea-
tures  during acute infection were examined.
Case  report  1
A four-year-old Afro-Brazilian girl with SCD type SC was
subjected to routine blood screening during her visit as an out-
patient  at the transfusion unit of the Hemotherapy Center of
Ribeirão  Preto, Brazil (September 3rd, 2010). The patient was
asymptomatic and her mother reported no complaints dur-
ing  the past week. The physical examination did not reveal
signs  of acute infection, such as fever, adenopathy or spleen
enlargement.
From  the laboratory results (Table 1) three ﬁndings
were  observed: the baseline hemoglobin had stable values
(10.5  g/dL, baseline 11.0 g/dL) on the background of a profound
reticulocytopenia (0.3% reticulocytes, range 0.66–2.19%) and
thrombocytopenia (122 × 103 L, baseline 201 × 103 L). B19V
was  suspected as a cause for the reticulocytopenia, although
the  patient was  asymptomatic. Therefore, the sample was
also  quantiﬁed for B19V by in-house developed TaqMan PCR
(see  Methods). The result was  positive with 1.2 × 10/10 viral
copies/mL, and although hospitalized for two days the patient
remained  asymptomatic without development of TAC. The
patient  was  anti-B19V IgG negative (OD = 0.115).
One month later (November 10th, 2010), the patient
returned to the Hemotherapy center for a medical evalua-
tion.  Her mother did not report complaints or indisposition
and the physical examination remained unchanged. Never-
theless,  a second blood sample was  tested for B19V. The
result  was  negative (rapid viral clearance) and the baseline
hemoglobin remained unchanged (10.6 g/mL). The platelets
and  the reticulocytes showed stabilization (Table 1). The phy-
logenetic  analysis of two partial viral genes (VP1 and NS1)232,000 398,000 434,000
11.27% 0.65% 4.5%
revealed  that the detected viral isolate belongs to subgeno-
type  1A of the main genotype 1 (97% bootstrap probabilities
for  VP1 and 93.6% for NS1, **p < 0.01) (Fig. 1A and B).
Case  report  2
A 10-year-old boy with S0-SCD suddenly developed serious
hypoplastic anemia on November 8th, 2010 and acute B19V
infection  was  suspected. The patient was pale and as the
condition  deteriorated progressively, he was hospitalized and
treated  by emergency blood transfusions (10 mL/kg of packed
red  cells). Additional symptoms included ﬁve-day history of
pain  in the arms and the legs, lethargy and malaise. The
day  before seeking medical care, the patient had episodes of
fever  and vomiting. The physical examination showed cervical
adenopathy, left upper quadrant tenderness and an enlarged
spleen.  Post-transfusion, the spleen decreased in size and the
blood  counts improved.
At  the time of the acute infection a blood sample was
collected for evaluation of the blood parameters, and for
B19V  detection. The hematological parameters displayed a
signiﬁcant drop of the hemoglobin (4.4 g/dL), reticulocytope-
nia (0.65%, baseline 11.27%), lympho- (14.4 × 103, baseline
3.9  × 103) and leukocytosis (18.2 × 103, baseline 11.9 × 103)
(Table 1). The B19V TaqMan PCR was  positive and demon-
strated 1.6 × 107 viral copies/mL. Although, high this viral load
was  signiﬁcantly lower than that of case report no. 1. Nev-
ertheless, this patient developed severe TAC, life-threatening
anemia and needed emergency transfusions. After blood
transfusion, the hemoglobin was  stabilized from 4.4 g/dL
(November 8th, 2010) to 8.1 g/dL (November 10th, 2010) but the
TAC  continued approximately one week. In this comparative
case,  the acute infection was connected with severe anemia,
as  well as life-threatening drop of the hemoglobin and hema-
tocrit  on the background of lymphocytosis, leukocytosis and
reticulocytopenia. The serologic detection of anti-B19V IgG at
the time of the collection of the molecular diagnosis demon-
strated  negative result (OD = 0,201 U/mL).The phylogenetic analysis of partial VP1 and NS1 gene
sequences demonstrated that the isolate belongs to subgeno-
type  1A of genotype 1 (97% bootstrap probabilities by the VP1
and  93.6% by the NS1 gene). This sequence formed one cluster
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Fig. 1 – Phylogenetic analysis of the detected human parvovirus B19 (B19V) isolates from acutely infected and asymptomatic
children with sickle cell disease. (A) Rooted NJ tree of the reference B19V genotypes and the sequences obtained from the
patients with acute (AF282) and asymptomatic infections (AF262) based on a 442 bp fragment of the NS1 region. The simian
parvovirus (SIM) is used as an outgroup; (B) Rooted NJ tree of the reference B19V genotypes and the sequences obtained
from the patients with acute (AF282) and asymptomatic infections (AF262) based on a 699 bp fragment of the VP1  region.
Simian parvovirus is also used as an outgroup. The posterior probabilities (above 75%, using 1000 bootstrap replicates) are
indicated at the clusters. The statistical evaluation of some important branches was  also performed by the Maximum
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ith the B19V isolate from the asymptomatic patient (Fig. 1A
nd B) with high similarity indicating the identity of the infect-
ng  subgenotypes.
The second blood sample obtained at the end of the
onth (November, 26th) showed a return of the hemoglobin
nd  reticulocyte levels to the patient’s baseline. Neverthe-
ess,  the sample was  positive for B19V with a low viral load
2.6  × 104 copies/mL). The patient did not show indisposition
r anemia deterioration.
ethods
amples  collection
ix milliliters of total blood were collected in sterile EDTA
ubes  (Becton Dickinson, USA) by brachial vein punc-
ure. Plasma was  separated by low-speed centrifugation
1426 × g/10 min). During plasma separation all precautions
ere  taken to avoid inter-sample contamination prior to viral
etection.  The family relatives of both children gave their
nformed  consent prior to B19V testing.Serological  conﬁrmation  of  B19V  infection
Anti-B19V IgG was  detected semi-quantitatively by the
Ridascreen® Parvovirus IgG kit (R-Biopharm AG, Germany),
following manufacturer’s instructions. The antibody titer
was  expressed in U/mL (negative < 0.3 U/mL, equivocal
0.3–0.5 U/mL and positive > 0.5 U/mL).
Quantiﬁcation  of  B19V  load
B19V DNA was extracted by the help of the QIAamp® Viral
RNA  Mini Kit (QIAGEN, Germany) following manufacturer’s
instructions. B19V infection was  diagnosed by the use of in-
house  optimized TaqMan real-time PCR as already described
by  Slavov SN and cols.9 To ensure the analytical veriﬁcation of
the  reaction, all appropriate controls were applied, including
599/800  WHO  B19 NAT standard (5 × 10 IU/mL, NIBSC, UK). In
order  to reduce the risk of B19V DNA contamination because
of  the high B19V viral load, all the diagnostic procedures (DNA
extraction,  sample application, master mix  preparation and
 i s . 2
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PCR) were performed in different laboratory rooms certiﬁed
for  molecular viral detection.
DNA  sequencing  and  phylogenetic  analysis
The sequencing was  performed in ABI 3130XL Genetic Ana-
lyzer  (Life Technologies, USA). The phylogenetic analysis was
carried  out on two partial genes: 442 bp fragment of the non-
structural  region (NS1) and 699 bp fragment of the VP1 region,
ampliﬁed  by established primer pairs.10 Multiple alignment
was  performed by ClustalW (BioEdit, Carlsbad, CA). Neighbor-
Joining  and Maximum Parsimony trees were reconstructed by
the program Phylip v 3.69 (Felsentstain J, University of Wash-
ington,  USA). Divergences between the clades were estimated
by  the Kimura-2-parameter using 1000 bootstrap replicates.
Only  values above 75% were  considered as signiﬁcant and the
statistical  evaluation of some important branch lengths was
also  performed by the Maximum Likelihood method (**p < 0.01
and  *p < 0.05).
Discussion
Although, B19V is a common pathogen in the general popu-
lation,  its clinical manifestations among children with SCD
are  poorly deﬁned. SCD is a chronic disease, characterized
by repeated vaso-occlusive and aplastic crises frequently trig-
gered  by a bacterial or viral infection.11 Despite the fact that
most  of the patients develop humoral anti-B19V response after
the  acute infection, it is not uncommon for patients with SCD
to  establish persistent viral carriage with unknown squeal.9
Although, B19V can persist for prolonged periods of time,12 the
detection  of high viral loads in plasma is indicative of acute
infection,  which was  observed in both diagnosed children,
despite the difference in the clinical picture.
In case report no. 1 (SCD type SC), the acute B19V infection
was  diagnosed occasionally without clinical symptomato-
logy. The only observation was  the profound reticulocytopenia
observed during routine blood testing. Nevertheless, due to
the high viral load, the lack of symptoms in this patient
is  unfamiliar. In case report no. 2, a child suffering from
SCD  type S0 developed acute B19V infection with profound
hemoglobin and reticulocyte drop needing emergency trans-
fusions.  Additional symptoms like fever, malaise, lethargy and
painful  crisis were also reported. Why  some children with SCD
and  acute B19V infection do not develop clinical symptoms
is  unclear. Probably, most important are the variable rates of
hemolysis  seen in different types of SCD. Some additional
factors such as fetal hemoglobin concentration, concurrent -
thalassemia, nutritional status and may  be B19V genotype can
alleviate the virally induced hematologic effects.7 The pres-
ence  of asymptomatic B19V infection in patients with SCD
has  other important aspect. Due to the high viral load, these
patients  can be responsible for nosocomial B19V outbreaks,
which  is probably our case as the asymptomatic infection
was  detected initially, and the severe several days after. Such
outbreaks  are connected with signiﬁcant morbidity among
individuals with hemoglobinopathies in transfusion centers.
Therefore,  the identiﬁcation, characterization and isolation of
the  asymptomatic cases are essential for prevention of such 0 1 3;1  7(1):97–101
outbreaks.  The acute symptoms in case report no. 2 can be
a  result from the excessive cytopathic B19V effect on bone
marrow  progenitors documented in patients with SCD type
S0, and their higher hemolysis rates. The examined patient
did  not exhibit rash and is believed that this could be a
result  from the antigen excess during acute B19V infection.13
Nevertheless, the observed splenomegaly in this patient can
additionally  contribute to the profound hemoglobin drop.
The  single stranded B19V DNA genome is variable14 and
currently is controversial how this can inﬂuence the outcome
of  the infection. Some authors15 indicate subgenotype 1A as
a  frequent cause of hemolytic disorders and related to blood
transfusion therapy, which is supported by the observation
of  patient no. 2, but not that of patient no. 1. The performed
phylogenetic analysis demonstrated that the detected iso-
lates  belong to subgenotype 1A (genotype 1). Moreover, both
sequences  formed one cluster, conﬁrmed by the analysis of
two  different partial genes (VP1 and NS1) (Fig. 1A and B),
demonstrating that the genotypic characteristics probably
have  limited importance for the outcome of B19V infection.
Conclusion
In summary, the comparison of asymptomatic and symp-
tomatic  acute B19V cases in pediatric patients with SCD is of
signiﬁcant  importance. On one hand, the current existence
of  advanced sequence and diagnostic procedures will provide
a  better understanding of the genetic variability of this com-
mon  viral pathogen and may  modify our understanding of the
natural  history of B19V infection in children with SCD. On the
other,  regarding the asymptomatic infections, we  may  need to
change our approach to issues like blood transfusion safety,
personal  risk of one particular patient with SCD to B19V and
ﬁnally  the education of the patients regarding TAC as a serious
and  potentially life-threatening complication.
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